黛力新、奥美拉唑联合治疗慢性胃炎伴反流性食管炎的效果分析

Treatment effect analysis of deanxit combined omeprazole in treatment of chronic gastritis with reflux esophagitis

目的探究对慢性胃炎伴反流性食管炎患者应用黛力新、奥美拉唑联合治疗方式实施救治的临床治疗结果。方法选取2015年7月～2017年9月新昌县人民医院接收诊治的慢性胃炎伴反流性食管炎患者120例作为研究样本，均为本院依据相关标准确诊的慢性胃炎伴反流性食管炎患者。并将其随机分为对照组和观察组，每组60例。对照组患者给予奥美拉唑、莫沙必利药物实施救治，观察组患者采取黛力新、奥美拉唑、莫沙必利联合治疗方式实施救治。观察并比较2组患者临床治疗有效率，给予对应治疗方式前、治疗1个月后、治疗2个月后反流性食管炎临床表征对应积分情况。结果治疗后，观察组患者临床治疗有效率为93.3%，对照组为83.3%，差异具有统计学意义（P＜0.05）。治疗前，2组患者的反流性食管炎临床表征对应积分情况对比，差异无统计学意义；治疗后，2组患者的反流性食管炎临床表征对应积分情况相较于治疗前，均呈现显著下降趋势，且观察组患者的反流性食管炎临床表征对应积分情况改善趋势显著优于对照组（P＜0.05）；给予对应治疗方式2个月后，2组患者的反流性食管炎临床表征对应积分情况相较于治疗1个月后，均呈现显著下降趋势（P＜0.05）。结论对慢性胃炎伴反流性食管炎患者应用黛力新、奥美拉唑联合治疗方式实施救治，临床治疗结果显著，对患者临床治疗有效率的提升具有积极的促进作用，同时有助于缩短患者在院治疗时间，加快患者病症的康复进程。

Objective To explore the clinical treatment of patients with chronic gastritis with reflux esophagitis dextrose and omeprazole combination therapy.Methods120patients with chronic gastritis and reflux esophagitis receiving diagnosis and treatment in our hospital from July2015to September2017were selected as the research samples and all of them were diagnosed chronic gastritis with reflux esophagitis in our hospital according to relevant standards.And they were randomly divided into two groups,control group and observation group,60cases in each group.Patients in the control group were treated with omeprazole and mosapride,and patients in the observation group were treated with dextromethorphan,omeprazole and mosapride.Observed and compared the clinical treatment of two groups of patients with efficiency,given the corresponding treatment,treatment January,after two months of treatment of reflux esophagitis clinical manifestations corresponding points.Results After the corresponding treatment was given,the effective rate of clinical treatment in the observation group was93.3%,which was significantly higher than that of the control group(83.3%,P<0.05).Before the corresponding treatment,the reflux esophagus There was no significant difference between the two groups in terms of the corresponding integrals of inflammation symptoms.After treatment,the clinical symptoms of reflux esophagitis in both groups showed a significant decrease compared with those before treatment.The clinical symptoms of reflux esophagitis in observation group were significantly better than those in control group(P<0.05).After two months of corresponding treatment,the clinical characteristics of reflux esophagitis in the two groups were similar to those of the control group Compared with the one month after treatment,all showed a significant downward trend(P<0.05).Conclusion The treatment of patients with chronic gastritis and reflux esophagitis using dextromethorphan and omeprazole combined treatment of the implementation of treatment,the clinical treatment of significant results in improving the clinical treatment of patients with a positive role in promoting the same time help to shorten the patient In hospital treatment time,speed up the rehabilitation process of the patient’s condition.